Advertisement
Medtronic
Subscribe to Medtronic
View Sample

FREE Email Newsletter

Medtronic's miss muddles the renal denervation landscape

January 13, 2014 7:29 am | by Mass Device | News | Comments

Medtech titan Medtronic (NYSE:MDT) rocked the renal denervation world when it reported earlier this month that it's bellwether Symplicity clinical trial failed to meet efficacy expectations when compared to a sham control arm. Physicians and...

Medtronic Renal Denervation Trial Fails to Meet Primary Efficacy Endpoint

January 9, 2014 11:19 am | by Medtronic | News | Comments

Medtronic, Inc. has announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet its primary efficacy endpoint. The trial met its primary safety endpoint, and the trial's...

Medtronic Announces Acquisition of TYRX, Developer of Solutions for Surgical Site Infections

January 6, 2014 12:06 pm | by Medtronic | News | Comments

Medtronic, Inc. today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug and implanted medical devices. TYRX's product offerings include the recently FDA cleared...

Advertisement

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

January 6, 2014 10:40 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of patients with persistent or long-standing persistent atrial fibrillation undergoing an ablation...

Medtronic to invest $6M, create 150 jobs in Puerto Rico expansion

December 23, 2013 2:58 pm | by Mass Device | News | Comments

Medtronic is launching a 3-year, $6 million project to boost its footprint on Puerto Rico, in a move that is slated to bring some 150 new jobs to the Caribbean island, according to Gov. Alejandro García Padilla. "Medtronic's expansion...   

St. Jude Medical halts Enlightn IV trial

December 10, 2013 3:30 pm | by Mass Device | News | Comments

St. Jude Medical is calling off the Enlightn IV trial of the next generation of its renal denervation technology, just a few months after it began. The trial of St. Jude's multi-electrode Enlightn device was slated to enroll about 590 patients...

Revisit Your Patent Licensing Practices Now

December 10, 2013 1:58 pm | by Orion Armon, Partner, Cooley LLP | Blogs | Comments

If your company licenses patented technology (in or out), it is time to revisit your licensing practices in light of recent (and anticipated) changes in patent law. In 2007, the U.S. Supreme Court held in MedImmune, Inc. v. Genentech, Inc...

First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

December 9, 2013 1:36 pm | by The Associated Press | News | Comments

Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc., today announced the first-in-human implant of the world's smallest pacemaker: the Micra Transcatheter Pacing System. The device was implanted...

Advertisement

Medtronic Presents First-of-Its-Kind Data Showing Sustained Results with Cervical Disc Replacement After Seven Years

December 6, 2013 10:06 am | by The Associated Press | News | Comments

Medtronic, Inc. presented 7-year clinical and radiographic outcomes of artificial disc replacement with PRESTIGE® Cervical Disc compared to anterior cervical discectomy and fusion (ACDF) yesterday at the Cervical Spine Research Society Annual...

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent, and Proven Outcomes in Real-World Setting

November 26, 2013 10:18 am | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graft system from Medtronic, Inc. continues to demonstrate long-term durability and consistent outcomes at three...

Appeals court affirms $10M Medtronic loss in catheter patent case

November 19, 2013 11:00 am | by Mass Device | News | Comments

A federal appeals court dealt a blow to Medtronic yesterday when it upheld a lower court's decision to award $10 million to the physician inventor of a patent involving catheters. The U.S. Court of Appeals for the Federal Circuit affirmed an...

Unexpectedly strong ICD sales for Medtronic buoy Boston Scientific

November 19, 2013 9:59 am | by Mass Device | News | Comments

Medtronic posted stronger-than-expected U.S. sales growth for its implantable cardioverter defibrillators, buoying shares of ICD rival Boston Scientific. Medtronic's U.S. ICD sales grew 3.9% during its fiscal 2014 2nd quarter ended Oct. 25, rising...

Trial Shows Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features

November 18, 2013 12:09 pm | by Medtronic | News | Comments

New research shows that Medtronic Inc. pacemakers with enhanced pacing features have the ability to slow the progression of atrial fibrillation (AF) in patients with bradycardia, or a slow heartbeat. Presented as a late breaking clinical trial...

Advertisement

FDA Issues Stern Warning on Medtronic Devices

November 16, 2013 7:19 pm | by David Koenig - AP Business Writer | News | Comments

Federal health officials say that defects in some Medtronic devices used in heart procedures are severe enough that they could cause serious injury or death. The warning covers about 15,000 recalled guidewires, which are inserted through an artery...

Medtronic Renal Denervation Device Offers Significant Drops in Blood Pressure After Treatment

October 31, 2013 2:39 pm | by Medtronic | News | Comments

Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running randomized, controlled clinical trial of renal denervation, which continue to demonstrate results consistent with data reported previously at six, 12...

Medtronic claims a win in European patent row with Edwards Lifesciences

October 30, 2013 10:58 am | by Mass Device | News | Comments

Medtronic is claiming a win in Europe in its patent row with Edwards Lifesciences over their competing transcatheter aortic valve implants. The European Patent Office issued a preliminary, non-binding ruling that the Edwards patent at the center of a...

Medtronic CoreValve U.S. Pivotal Trial Results Reveal Positive Outcomes for Patients

October 29, 2013 2:25 pm | by Medtronic | News | Comments

Medtronic, Inc. today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on the Medtronic CoreValve® System. The study of the novel self-expanding device, presented at a late-breaking...

TCT 2013: Higher pacemaker rate marks difference between Medtronic's, Edwards Lifesciences' TAVI devices

October 28, 2013 6:28 pm | by Mass Device | News | Comments

Results from the PRAGMATIC Plus analysis of Edwards Lifesciences' Sapien transcatheter aortic valve implantation system and Medtronic's rivaling CoreValve device found few differences between the devices, with the exception of lower rates of...

TCT 2013: Renal denervation does everything

October 28, 2013 4:35 pm | by Mass Device | News | Comments

Renal denervation may have lost some of its hype over the course of the last year, but researchers are still findings new ways to utilize the technology to target new diseases. Technologies such as Medtronic's Symplicity and St. Jude Medical's...

Will preemption rescue Medtronic from InFuse lawsuits?

October 24, 2013 1:27 pm | by Mass Device | News | Comments

Medtronic could avoid a major headache if the courts continue to allow the doctrine of preemption in product liability lawsuits filed over its InFuse bone-growth protein, according to Fish & Richardson principal José Sierra. The InFuse bone growth...

Medtronic Launches New Device to Remove Coronary Thrombus

October 21, 2013 12:01 pm | by Medtronic | News | Comments

With more than a decade of market leadership in medical devices designed to remove thrombus from coronary arteries, Medtronic has announced the U.S. launch of the Export Advance aspiration catheter, which offers ...    

Medtronic can't shake negligence lawsuit over Transvene defibrillator lead

October 16, 2013 3:11 pm | by Mass Device | News | Comments

Medtronic can't use preemption to shake a negligence lawsuit filed over a failed Transvene defibrillator lead, an Indiana appeals court ruled last week. The Court of Appeals of Indiana denied the Fridley, Minn.-based medical device company's bid...

Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to India

October 9, 2013 5:06 am | by The Associated Press | News | Comments

Apollo Hospitals Enterprise Ltd., one of the leading healthcare providers in Asia, and Medtronic, Inc. (NYSE: MDT), the global leader in medical technology, today announced a collaboration to bring to market an innovative, affordable and portable...

FDA Advisory Panel Recommends Expanded Indication for Medtronic's CRT Devices

October 8, 2013 6:06 pm | by The Associated Press | News | Comments

The U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices Advisory Panel today voted that biventricular (BiV) pacing with Medtronic, Inc. (NYSE: MDT) devices is beneficial for treating patients who have atrioventricular (AV) block...

Independent Study Examines Battery Life in CRT-D Devices

October 8, 2013 5:45 pm | by PR Newswire | News | Comments

An independent and first-of-its-kind study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, shows there are significant differences in battery longevity between contemporary cardiac resynchronization...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading